MoCo biopharma Sirnaomics more than triples footprint with new HQ


The 15-year-old company, which develops treatments for a range of diseases, has yet to bring a product to market.

Previous RI lab settles drug-testing kickback allegations with Mass. AG
Next Penn Medicine establishes Center for Living Donation to boost kidney, liver transplants